Barclays »

Immuneering Corp - Class A shares owned by Barclays

Quarter-by-quarter ownership of Immuneering Corp - Class A (IMRX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Immuneering Corp - Class A

Tip: Access up to 7 years of quarterly data

All positions including Immuneering Corp - Class A held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immuneering Corp - Class A by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $75k 26k 2.91
2023-12-31 $257k 35k 7.36
2023-09-30 $63k 8.2k 7.70
2023-06-30 $82k 8.1k 10.07
2023-03-31 $51k 5.2k 9.78
2022-12-31 $33k 6.8k 4.89
2022-09-30 $65k 4.6k 14.20
2022-06-30 $22k 4.2k 5.29
2022-03-31 $47k 7.2k 6.50